ABBV

AbbVie News

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
AbbVie Inc ABBV NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
1.02 0.95% 107.91 20:00:00
Open Price Low Price High Price Close Price Prev Close
107.37 107.14 108.5499 107.91 106.89
more quote information »

Recent News

Date Time Source Heading
4/15/202113:11EDGARNotice of Exempt Solicitation. Definitive Material...
4/07/202109:01PRNUSAbbVie Submits Regulatory Applications for SKYRIZI®..
4/07/202108:00PRNUSAbbVie to Present Data Across its Robust Neuroscience..
4/02/202122:51SEEKFDA extends review of Abbvie's sNDA for Rinvoq in atopic..
4/02/202118:23DJNFDA Extends Review of AbbVie's Skin Drug Application
4/02/202117:18PRNUSAbbVie Announces Extension of Review for Supplemental New..
4/01/202117:10EDGARStatement of Changes in Beneficial Ownership (4)
4/01/202117:10EDGARStatement of Changes in Beneficial Ownership (4)
4/01/202117:10EDGARStatement of Changes in Beneficial Ownership (4)
4/01/202108:45PRNUSSkinMedica® Launches Neck Correct Cream for Neck and..
4/01/202108:31PRNUSNew England Journal of Medicine Publishes 24-Week Results..
3/31/202114:19EDGARNotice of Exempt Solicitation. Definitive Material...
3/31/202108:00PRNUSAbbVie to Host First-Quarter 2021 Earnings Conference Call
3/30/202108:50DJNAbbVie: FDA to Review Atogepant for Preventive Treatment of..
3/30/202108:46SEEKFDA accepts Abbvie's atogepant application for migraine
3/30/202108:00PRNUSU.S. FDA Accepts AbbVie's New Drug Application for Atogepant..
3/29/202110:57EDGARNotice of Exempt Solicitation. Definitive Material...
3/24/202108:45NNWControlling Inflammation to Stop Disease
3/22/202117:03EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
3/22/202117:01EDGARProxy Statement (definitive) (def 14a)
3/22/202114:14SEEKAbbvie veteran joins Novartis as Chief Legal Officer
3/17/202112:01DJNAbbVie Down Over 6%, On Pace for Largest Percent Decrease..
3/17/202109:50DJNAbbVie: FDA Seeks More Data, Extends Rinvoq Review
3/17/202109:15SEEKAbbvie shares fall 6% following FDA review extension for..
3/17/202108:45PRNUSAbbVie Announces Extension of Review for Supplemental New..
3/15/202119:05SEEKAbbVie in talks to sell $5B women's drugs portfolio -..
3/12/202117:03EDGARCurrent Report Filing (8-k)
3/08/202117:28EDGARProxy Statement - Notice of Shareholders Meeting..
3/07/202105:59DJNHaving Trouble Getting the Covid Vaccine? Your Company Might..
3/01/202107:40SEEKAbbVie to sell Allergan Biologics to Pharmaron for $119..
2/26/202113:58DJNWarren Buffett's Annual Letter Is About to Land
2/25/202108:58DJNAbbVie's Allergan Seeks FDA OK of AGN-190584 in Presbyopia
2/25/202108:10SEEKAllergan submits AGN-190584 NDA for presbyopia treatment
2/25/202108:00PRNUSAllergan, an AbbVie Company, Submits New Drug Application..
2/25/202107:39SEEKAbbVie's HUMIRA wins FDA approval for ulcerative colitis
2/24/202119:14PRNUSHUMIRA® (adalimumab) Receives FDA Approval to Treat..
2/24/202118:29EDGARStatement of Changes in Beneficial Ownership (4)
2/24/202112:02DJNAbbVie: Skyrizi to Treat Psoriasis Gets Public Payer..
2/24/202111:21PRNCASKYRIZI®, commercialisé par AbbVie pour le traitement du..
2/24/202111:09PRNCAAbbVie's SKYRIZI® for the Treatment of Moderate to Severe..
2/24/202109:32SEEKEvolus cut to hold from buy at Truist
2/23/202108:30PRNUSNew REFRESH® DIGITAL Lubricant Eye Drops Tackle Eye Dryness..
2/22/202118:26EDGARStatement of Changes in Beneficial Ownership (4)
2/22/202118:25EDGARStatement of Changes in Beneficial Ownership (4)
2/22/202118:24EDGARStatement of Changes in Beneficial Ownership (4)
2/22/202118:23EDGARStatement of Changes in Beneficial Ownership (4)
2/22/202118:20EDGARStatement of Changes in Beneficial Ownership (4)
2/22/202118:19EDGARStatement of Changes in Beneficial Ownership (4)
2/22/202118:19EDGARStatement of Changes in Beneficial Ownership (4)
2/22/202118:18EDGARStatement of Changes in Beneficial Ownership (4)
See more news about this stock »


Your Recent History
NYSE
ABBV
AbbVie
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.